Transmembrane 6 superfamily member 2 (TM6SF2) variants are also strongly associated with the presence of NAFLD and have been correlated with the severity of steatosis, NASH, and cirrhosis [70,71]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatohepatitis.